宫内球囊填塞持续时间与产后出血结局的关联
该回顾性队列研究纳入2007至2014年因产后出血接受宫内球囊填塞的274例产妇,比较填塞2-12小时与超过12小时者的产后出血相关结局。填塞超过12小时组产后发热频率更高(27% vs 15%,P=0.047),校正后比值比为2.33(95%CI 1.07-5.11)。作者认为若出血已停止,可考虑在初次放置后12小时内取出球囊。
要点
- 填塞超过12小时与2-12小时相比,产后出血相关结局无显著差异。
- 填塞超过12小时组产后发热频率更高(27% vs 15%,P=0.047)。
- 若持续出血已停止,作者认为可考虑在放置后12小时内取出球囊。
核心结论
- 与2-12小时取出相比,宫内球囊填塞持续时间超过12小时与产后出血相关结局无显著差异。
- 若持续出血已停止,作者认为可考虑在初次放置后12小时内取出宫内球囊。
研究设计与样本
- 回顾性队列研究,纳入2007年至2014年因产后出血接受宫内球囊填塞的产妇。
- 排除球囊填塞失败者(球囊排出且持续时间<2小时,或计划取出球囊前需行子宫切除术)。
- 共274例符合条件,其中206例(75%)填塞超过12小时,68例(25%)填塞2-12小时。
- 采用多变量逻辑回归模型控制混杂变量。
主要发现
- 填塞后中位估计失血量:超过12小时组190 mL vs 2-12小时组143 mL(P=0.116)。
- 输血频率:超过12小时组62.1% vs 2-12小时组51.5%(P=0.120)。
- 输注≥4单位浓缩红细胞:超过12小时组17.0% vs 2-12小时组14.7%(P=0.659)。
- 子宫动脉栓塞:超过12小时组15.1% vs 2-12小时组16.2%(P=0.823);子宫切除术:0.0% vs 1.5%(P=0.248);ICU入住:8.7% vs 7.4%(P=0.721),均无统计学差异。
- 填塞超过12小时与产后发热频率更高(27% vs 15%,P=0.047)及平均住院时间更长(3.7天 vs 3.1天,P=0.002)相关;校正后住院时间差异不再存在,产后发热关联持续(OR 2.33,95%CI 1.07-5.11);事后多变量分析纳入绒毛膜羊膜炎后,该关联减弱(校正OR 2.04,95%CI 0.92-4.53)。
临床怎么用
- 作者认为若持续出血已停止,可考虑在宫内球囊初次放置后12小时内取出。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrauterine balloon tamponade is an effective treatment for postpartum hemorrhage when first-line treatments fail. The optimal duration of intrauterine balloon tamponade for management of postpartum hemorrhage is unclear. OBJECTIVE: The objective of the study was to determine whether intrauterine balloon tamponade removal >12 hours of duration is associated with postpartum hemorrhage-related clinical outcomes. STUDY DESIGN: This was a retrospective cohort study of women with postpartum hemorrhage from 2007 through 2014 who underwent intrauterine balloon tamponade. We excluded failures of intrauterine balloon tamponade (intrauterine balloon expulsion with duration <2 hours or if hysterectomy was required prior to planned intrauterine balloon removal). Patients who underwent intrauterine balloon tamponade for 2-12 hours were compared with those who underwent intrauterine balloon tamponade for >12 hours. Examined postpartum hemorrhage-related clinical outcomes included estimated blood loss after intrauterine balloon tamponade placement, blood product transfusion, use of adjuvant measures to control postpartum hemorrhage after intrauterine balloon tamponade (either uterine artery embolization or hysterectomy), and maternal intensive care unit admission. Secondary outcomes examined included postpartum fever and hospital length of stay. Multivariable logistic regression models were used to control for confounding variables. RESULTS: Of 274 eligible women, 206 (75%) underwent intrauterine balloon tamponade for >12 hours and 68 (25%) underwent intrauterine balloon tamponade for 2-12 hours. The median estimated blood loss after intrauterine balloon tamponade placement (190 vs 143 mL, P = .116) as well as the frequencies of blood product transfusion (62.1% vs 51.5%, P = .120), transfusion of ≥4 U of packed red blood cells (17.0% vs 14.7%, P = .659), uterine artery embolization (15.1% vs 16.2%, P = .823), hysterectomy (0.0% vs 1.5%, P = .248), and intensive care unit admission (8.7% vs 7.4%, P = .721), was not statistically different between the groups, and this lack of association persisted in multivariable regressions. Intrauterine balloon tamponade duration >12 hours was associated with a higher frequency of postpartum fever (27% vs 15%, P = .047) and a longer mean hospital length of stay (3.7 vs 3.1 days, P = .002). After adjusting for variables that differed statistically between groups, the difference in length of stay associated with intrauterine balloon tamponade duration was no longer present, but the association between intrauterine balloon tamponade duration >12 hours and postpartum fever persisted (odds ratio, 2.33, 95% confidence interval, 1.07-5.11). Including chorioamnionitis as an independent variable in a post hoc multivariable analysis diminished the association between intrauterine balloon tamponade >12 hours and postpartum fever (adjusted odds ratio, 2.04, 95% confidence interval, 0.92-4.53). CONCLUSION: There are no significant differences in postpartum hemorrhage-related outcomes associated with intrauterine balloon tamponade duration >12 hours compared with removal 2-12 hours. If ongoing hemorrhage has abated, it is reasonable to consider the removal of an intrauterine balloon by 12 hours after its initial placement.
引用
- Einerson BD, Son M, Schneider P, et al. The association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes. Am J Obstet Gynecol. 2016. PMID: 27823918. doi:10.1016/j.ajog.2016.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。